disease progression

Type: Keyphrase
Name: disease progression
Publicerad 21 hours ago - uppdaterad 4 hours ago - 2 rapporter

Cinnamon may help in halting progress of Parkinson's disease

A recent study has revealed that cinnamon can suspend biomechanical, cellular and anatomical changes that occur in the brain due to Parkinson's disease.Neurological scientists at Rush University Medical Center have found that using cinnamon, a common ... [Published Business Standard India - 4 hours ago]
Publicerad Jul 08 2014 - uppdaterad Jul 09 2014 - 1 rapporter

Alzheimer's Predictions

Researchers report a set of proteins that can predict Alzheimer's disease progression. read more ... [Published The Daily Scan from GenomeWeb - Jul 08 2014]
Publicerad Jul 08 2014 - uppdaterad Jul 08 2014 - 1 rapporter

IL-10 and Lymphotoxin-α Expression Profiles within Marginal Zone-Like B-Cell Populations Are Associated with Control of HIV-1 Disease Progression

by Josiane Chagnon-Choquet, Julie Fontaine, Johanne Poudrier, Michel Roger, for the Montreal Primary HIV Infection and Slow Progressor Study GroupsUnderstanding how the immune system facilitates or controls HIV-1 disease progression has important implications ... [Published Plosone.org - Jul 08 2014]
Publicerad Jul 08 2014 - uppdaterad Jul 08 2014 - 1 rapporter

Everolimus fails to extend life in advanced liver cancer

Survival rates in patients with advanced liver cancer are not improved by the mTOR inhibitor everolimus, the EVOLVE-1 clinical trial suggests1. The study followed 546 adults with advanced hepatocellular carcinoma (HCC) who were intolerant to or had experienced ... [Published PJ Online - Jul 08 2014]
Publicerad Jul 08 2014 - uppdaterad Jul 08 2014 - 2 rapporter

New test predicts survival and disease progression in blood cancer patients

Scientists have developed a test which accurately predicts the prognosis for patients with the most common form of leukaemia.The findings could also inform the development of a prognostic test for patients with other forms of cancer.Researchers f...Related ... [Published BioPortfolio - Jul 08 2014]
Publicerad Jul 08 2014 - uppdaterad Jul 08 2014 - 1 rapporter

Beyond scoring: a modern histological assessment of chronic hepatitis should include tissue angiogenesis

Advanced searchWe read with great interest the leading article by Rosselli et al1We fully agree with the view that the histological scoring of fibrosis is a reductive approach to the assessment of CLDs, as it does not fully reflect the complex events ... [Published British Journal of the Gut - Jul 08 2014]
Publicerad Jul 07 2014 - uppdaterad Jul 07 2014 - 1 rapporter

New Nanoparticles Simultaneously Kill Cancer And Strengthen Bones

By A collaborative research team made up of scientists from the Dana-Farber Cancer Institute and Brigham and Women’s Hospital (BWH) has devised a new method for helping to prevent and treat bone cancer that uses nanoparticles to deliver drugs directly ... [Published Medical Design Online - Jul 07 2014]
Publicerad Jul 05 2014 - uppdaterad Jul 05 2014 - 1 rapporter

A double-blind, randomized controlled trial to compare the effect of biannual peripheral magnetic ...

Permanent joint damage is a major consequence of rheumatoid arthritis (RA), the most common and destructive form of inflammatory arthritis. In aggressive disease, joint damage can occur within 6 months from symptom onset.Early, intensive treatment with ... [Published 7thSpace - Jul 05 2014]
Publicerad Jul 04 2014 - uppdaterad Jul 04 2014 - 1 rapporter

Influence of HLA Class I Haplotypes on HIV-1 Seroconversion and Disease Progression in Pumwani Sex Worker Cohort

by Raghavan Sampathkumar, Harold O. Peters, Lillian Mendoza, Thomas Bielawny, Elizabeth Ngugi, Joshua Kimani, Charles Wachihi, Francis A. Plummer, Ma LuoWe examined the effect of HLA class I haplotypes on HIV-1 seroconversion and disease progression in ... [Published Plosone.org - Jul 04 2014]
Publicerad Jul 04 2014 - uppdaterad Jul 04 2014 - 1 rapporter

Early trial of PET tracer shows promise for brain tumors

Researchers at the University of Wisconsin's UW Health system have completed the first successful human clinical trial of a new PET radiopharmaceutical that targets and detects brain tumors more specifically than FDG.Iodine-124 (I-124) CLR1404 is designed ... [Published US Society of Nuclear Medicine - Jul 04 2014]
Entiteter: TRACER, Tumor, Stem Cell, Cancer
Publicerad Jun 23 2014 - uppdaterad Jun 24 2014 - 7 rapporter

FDA staff question benefit of AstraZeneca ovarian cancer drug

AstraZeneca Plc's experimental ovarian cancer drug, olaparib, showed an 83 percent reduction in the risk of disease progression, but a U.S. Food and Drug Administration staff review has questioned whether the result could be reproduced. The c... ... [Published Yahoo! Health News - Jun 23 2014]
Publicerad Jun 19 2014 - uppdaterad Jun 20 2014 - 4 rapporter

StemCells, Inc. Interim Results Show Improvement in Visual Function and Slowing of Disease Progression in Phase I/II Dry AMD Trial

You currently are not registered for any FirstWord Pharma services.Register to FirstWord Pharma for free access to 10 articles every 30 days: StemCells, Inc. Interim Results Show Improvement in Visual Function and Slowing of Disease Progression in Phase ... [Published FirstWord Pharma - Jun 19 2014]


"Cinnamon has been used widely as a spice throughout the world for centuries," lead researcher of the study Dr Pahan, said in a news release . "This could potentially be one of the safest approaches to halt disease progression in Parkinson's patients."
...walking ability] for the treatment and placebo cohorts but nothing like what we see in the natural history studies of Duchenne," said Garabedian. "These boys are still doing well relative to their age and where they started with their disease progression."
"The vast majority of tumor cells are associated with blood vessels. These cells appear to be using the vessels as highways to travel great distances within the brain" said Dr. Sontheimer
Johan Häggblad, Managing Director of Pharmalink, said: "Nefecon is a disease-modifying medication and one of the first specifically aimed at addressing the underlying pathology of progressive IgA nephropathy. The issuance of core patents in key global markets reinforces the commercial package we are building around Nefecon."

Mer innehåll

Alla (912) | Nyheter (785) | Rapporter (0) | Bloggar (113) | Ljud/Video (0) | Faktablad (1) | Pressreleaser (6)
sort by: Date | Relevance
Time-averaged albumin predicts the long-term pr... [Published 7thSpace - 1 hour ago]
Down 17%: Is Sarepta a Bad News Buy? [Published Motley Fool - 1 hour ago]
Researchers find interferon has both detrimenta... [Published Medical Xpress - 1 hour ago]
What does ‘value’ mean in Healthcare? [Published eyeforpharma.com - 1 hour ago]
Cinnamon May Help Treat Parkinson's Disease: Study [Published International Business Times India - 3 hours ago]
Differential Scaling of GFR and Ingested Metabo... [Published General Medicine eJournal - 4 hours ago]
Cinnamon may help in halting progress of Parkin... [Published Business Standard India - 4 hours ago]
Latest Sarepta Study Update Shows Greater Decli... [Published TheStreet.com - 4 hours ago]
Latest Sarepta Study Update Shows Greater Decli... [Published The Street Latest - 5 hours ago]
Brain tumor cells disrupt the brain's protectiv... [Published Medical News Today - 6 hours ago]
Pharmalink’s core patents for Nefecon issued in... [Published News-Medical.Net - 8 hours ago]
Pharmalink's Core Patents for Nefecon® Treatmen... [Published Good Day Sacramento - 10 hours ago]
We don't know how many children have TB, and we... [Published Conversation UK - 12 hours ago]
Ado-Trastuzumab Emtansine as a Late Treatment f... [Published The ASCO Post - 15 hours ago]
Multi-modality imaging of a murine mammary wind... [Published Bio Techniques - 15 hours ago]
Cinnamon might slow Parkinson's, research suggests [Published CNET News - 18 hours ago]
New Study – Cinnamon Reverses, Halts Progressio... [Published Nutrition Review - 19 hours ago]
Ipilimumab Reduces Recurrences as Adjuvant Trea... [Published The ASCO Post - 20 hours ago]
Modest Improvement in Progression-Free but Not ... [Published The ASCO Post - 20 hours ago]
Siltuximab for Multicentric Castleman’s Disease [Published The ASCO Post - 20 hours ago]
ASCO Clinical Practice Guideline: Disease Manag... [Published The ASCO Post - 20 hours ago]
2001 Young Investigator Award Recipient Pasi Jä... [Published The ASCO Post - 20 hours ago]
AR-V7 Predicts Resistance to Enzalutamide and A... [Published The ASCO Post - 20 hours ago]
Cinnamon May Halt Parkinson's Progression: Rese... [Published NewsMax.com - 21 hours ago]
Ten Years of Targeted Treatment in Lung Cancer [Published Medical Grapevine - 21 hours ago]
Psoriasis Treatment Pipeline Features Innovativ... [Published P&T Community - 22 hours ago]
Al Pilong: Heart Failure Clinic helps residents... [Published Record-Eagle - Jul 09 2014]
Adocia Announces Approval to Start a Phase IIa ... [Published FinanzNachrichten.de - Jul 09 2014]
MyChart Use Skyrocketing Among Cancer Patients [Published Newswise - Jul 09 2014]
Psoriasis Treatment Pipeline Shows High Level o... [Published TickerTech.com - Jul 09 2014]
1 2 3 4 5 6 7 8 9 10 ...
I fokus
Document Volume


sort by: Date | Relevance
Alzheimer's Predictions [Published The Daily Scan from GenomeWeb - Jul 08 2014]
Managing urinary tract infections in multiple s... [Published Multiple Sclerosis Research - Jul 04 2014]
Rotation Medical snags $27.2 mln Series B [Published PE Hub Blog - Jul 02 2014]
Spinal cord loss associated with disability [Published Multiple Sclerosis Research - Jun 29 2014]
Do DMTs delay the onset of secondary progressiv... [Published Multiple Sclerosis Research - Jun 27 2014]
1 2 3 4 5 6 7 8 9 10 ...


sort by: Date | Relevance
StemCells, Inc. Interim Results Show Improvemen... [Published GlobeNewswire: Advertising News - Jun 19 2014]
PatientsLikeMe and Sage Bionetworks Launch Open... [Published PatientsLikeMe Press Release - Feb 05 2014]
NeuroPhage to Participate in World's First G8 D... [Published PR Newswire - Dec 03 2013]
Revalesio Initiates Phase IIa Study of RNS60 in... [Published PR Newswire - Nov 11 2013]
COMS Interactive Launches OPAL Award Program [Published PR Newswire - Oct 31 2013]
1 2
Contact Us

Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.